Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.62 -1.59%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
ECX, ONON, LODE, More
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synthesis Energy Systems (SES) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
- Theriva Biologics (TOVX) Misses Q2 EPS by 1c
- Evolv Technology (EVLV) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
